ABCZF Stock: Abcam plc Stock Price, Analysis & Insights
Get live abczf stock price $22.25, comprehensive Abcam plc stock analysis, charts, news, and expert forecast. Real-time abczf stock data and investment insights.
Company Overview
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Company Information
- CEO
- Markus Lusser
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 1760
Contact Information
- Website
- https://www.abcam.com
- Address
- Discovery Drive
- Country
- GB
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 5.67B market capitalization
- Trading Volume: 4.00K shares traded today
- Price Range: 52-week range of $22.25 - $22.25
- Exchange: Listed on Other OTC
Financial Metrics
Market Analysis for Abcam plc
Abcam plc (ABCZF) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 5.67B, the company represents a significant player in its market. The stock is currently trading at $22.25 with a positivedaily change of 0.68%.
The company's 1760 employee base and presence on the Other OTCexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 2225.00, beta of 0.86, and 52-week price range from $22.25 to $22.25when evaluating investment opportunities.
Why Invest in Abcam plc?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (Other OTC)
- • Experienced leadership under Markus Lusser
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.